Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000865882 | SCV001006908 | benign | X-linked severe congenital neutropenia; Thrombocytopenia 1; Wiskott-Aldrich syndrome | 2023-12-27 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001816974 | SCV002070130 | uncertain significance | not specified | 2020-02-14 | criteria provided, single submitter | clinical testing | DNA sequence analysis of the WAS gene demonstrated a sequence change, c.1181C>T, in exon 10 that results in an amino acid change, p.Pro394Leu. This sequence change has been described in the gnomAD database with a frequency of 0.12% in the African sub-population (dbSNP rs373524969). The p.Pro394Leu change has been identified in a patient with primary immunodeficiency disease (PMID: 27577878). The p.Pro394Leu change affects a highly conserved amino acid residue located in a domain of the WAS protein that is not known to be functional. In-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL) provide contradictory results for the p.Pro394Leu substitution. Due to these contrasting evidences and the lack of functional studies, the clinical significance of the p.Pro394Leu change remains unknown at this time. |